Cite
HARVARD Citation
Rebuzzi, S. et al. (2021). Inflammatory indices and clinical factors in metastatic renal cell carcinoma patients treated with nivolumab: the development of a novel prognostic score (Meet-URO 15 study). Therapeutic advances in medical oncology. p. . [Online].